참고문헌 (56)

1. 1 Brookmeyer R , Johnson E , Ziegler-Graham K , Arrighi HM . Forecasting the global burden of Alzheimer’s disease . Alzheimer's & dementia , 2007 , 3 ( 3 ): 186 – 191 . 

   상세보기

2. 2 Gatz M , Reynolds CA , Fratiglioni L , Johansson B , Mortimer J A , Berg S , et al Role of genes and environments for explaining Alzheimer disease . Arch Gen Psychiatry , 2006 , 63 ( 2 ): 168 – 74 . 16461860 

   상세보기

3. 3 Waring SC , Rosenberg RN . Genome-wide association studies in Alzheimer disease . Archives of Neurology , 2008 , 65 ( 3 ): 329 – 34 . 10.1001/archneur.65.3.329 18332245 

   상세보기

4. 4 Francis PT , Palmer AM , Snape M , Wilcock GK . The Cholinergic Hypothesis of Alzheimer's Disease: a Review of Progress . Journal of Neurology, Neurosurgery, and Psychiatry , 1999 , 66 ( 2 ): 137 – 47 . 10071091 

   상세보기

5. 5 Hardy J , Allsop D . Amyloid Deposition as the Central Event in the Aetiology of Alzheimer's Disease . Trends in Pharmacological Sciences . 1991 , 12 ( 10 ): 383 – 88 . 1763432 

6. 6 Goedert M , Spillantini MG , Crowther RA . Tau Proteins and Neurofibrillary Degeneration . Brain Pathology (Zurich, Switzerland) . 1991 , 1 ( 4 ): 279 – 86 . 1669718 

   상세보기

7. 7 Itzhaki RF , Wozniak MA . Herpes Simplex Virus Type 1 in Alzheimer's Disease: The Enemy Within . Journal of Alzheimer's Disease . 2008 [Retrieved 5 February 2011], 13 ( 4 ): 393 – 405 . 18487848 

   상세보기

8. 8 Shcherbatykh I , Carpenter DO . The Role of Metals in the Etiology of Alzheimer's Disease . Journal of Alzheimer's Disease . 2007 , 11 ( 2 ): 191 – 205 . 17522444 

   상세보기

9. 9 Feldman H , Gauthier S , Hecker J , Vellas B , Subbiah P , Whalen E , et al A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease . Neurology , 2001 , 57 ( 4 ): 613 – 620 . 11524468 

   상세보기

10. 10 Sabbagh M , Cummings J . Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology . BMC neurology , 2011 , 11 ( 1 ): 21 . 21299848 

11. 11 Wang Y , Huang L , Tang X , Zhang HY . Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia . Acta Pharmacologica Sinica , 2010 , 31 ( 6 ): 649 – 664 . 10.1038/aps.2010.46 20523337 

    상세보기

12. 12 Han Y , Lin L , Xi CT . Treating senile dementia with Traditional Chinese Medicine . Clin Interv Aging , 2007 , 2 ( 2 ): 201 – 208 . 18044136 

13. 13 Zhang S J , Xue Z Y . Effect of Western medicine therapy assisted by Ginkgo bilobatablet on vascular cognitive impairment of none dementia . Asian Pacific journal of tropical medicine , 2012 , 5 ( 8 ): 661 – 664 . 10.1016/S1995-7645(12)60135-7 22840457 

    상세보기

14. 14 Liu P , Kong M , Liu S , Chen G , Wang P . Effect of reinforcing kidney-essence, removing phlegm, and promoting mental therapy on treating Alzheimer's disease . Journal of Traditional Chinese Medicine , 2013 , 33 ( 4 ): 449 – 454 . 24187864 

    상세보기

15. 15 Bi M , Tong S , Zhang Z , Ma Q , Zhang S , Luo Z , et al Changes in cerebral glucose metabolism in patients with mild-to-moderate Alzheimer's disease: A pilot study with the Chinese herbal medicine fuzhisan . Neuroscience letters , 2011 , 501 ( 1 ): 35 – 40 . 10.1016/j.neulet.2011.06.036 21741446 

    상세보기

16. 16 Miao Y C , Tian J Z , Shi J , Mao M . Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial . Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine , 2012 , 10 ( 4 ): 390 22500712 

17. 17 Luo Y , Nie J , Gong Q H , Lu Y F , Wu Q , Shi JS . Protective effects of icariin against learning and memory deficits induced by aluminium in rats . Clin. Exp. Pharmacol. Physiol . 2007 , 34 ( 8 ), 792 – 795 . 17600559 

    상세보기

18. 18 Nie J , Luo Y , Huang X N , Gong Q H , Wu Q , Shi J S . Icariin inhibits beta-amyloid peptide segment 25–35 induced expression of β-secretase in rat hippocampus . European journal of pharmacology , 2010 , 626 ( 2 ): 213 – 218 . 10.1016/j.ejphar.2009.09.039 19782061 

    상세보기

19. 19 Fan LH , Wang KZ , Cheng B , Wang C S , Dang X Q . Antiapoptotic and neuroprotective effects of tetramethylpyrazine following spinal cord ischemia in rabbits . BMC Neurosci . 2006 , 7 ( 1 ): 48 – 52 . 16774675 

20. 20 Cheng X R , Zhang L , Hu J J , Sun L , Du G H . Neuroprotective effects of tetramethylpyrazine on hydrogen peroxide-induced apoptosis in PC12 cells . Cell Biol Int , 2007 , 31 : 438 – 43 . 17321170 

    상세보기

21. 21 Lei H , Wang B , Li WP , Yang Y , Zhou A W , Chen M Z . Anti-aging effect of astragalosides and its mechanism of action . Acta Pharmacol Sin , 2003 , 24 ( 3 ): 230 – 234 . 12617771 

22. 22 Tohda C , Tamura T , Matsuyama S , Komatsu K . Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus . British journal of pharmacology , 2006 , 149 ( 5 ): 532 – 541 . 16981006 

    상세보기

23. 23 Mungas D . In-office mental status testing: a practical guide . Geriatrics , 1991 , 46 ( 7 ): 54 – 58 , 63 , 66 2060803 

    상세보기

24. 24 Cummings J L , Mega M , Gray K , Rosenberg-Thompson S , Carusi D A , Gornbein J . The Neuropsychiatric Inventory comprehensive assessment of psychopathology in dementia . Neurology , 1994 , 44 ( 12 ): 2308 7991117 

    상세보기

25. 25 Cummings J L , Fairbanks L , Masterman D L . Strategies for analysing behavioural data in clinical trials involving patients with Alzheimer's disease . The International Journal of Neuropsychopharmacology , 1999 , 2 ( 1 ): 59 – 66 . 11281971 

    상세보기

26. 26 Rogers S L , Farlow M R , Doody R S , Mohs R , Friedhoff L T . A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease . Neurology , 1998 , 50 ( 1 ): 136 – 145 . 9443470 

    상세보기

27. 27 Lange S , Freitag G . Choice of delta: requirements and reality—results of a systematic review . Biom J , 2005 , 47 ( 1 ): 12 – 27 , 99 – 107 . 16395993 

28. 28 Burns A , Rossor M , Hecker J , Gauthier S , Petit H , Moller H J , et al The Effects of Donepezil in Alzheimer’s Disease—Results from a Multinational Trial . Dementia and geriatric cognitive disorders , 1999 , 10 ( 3 ): 237 – 244 . 10325453 

29. 29 Cummings J L . Alzheimer’s disease . N Engl J Med . 2004 , 351 ( 1 ): 56 – 67 . 15229308 

    상세보기

30. 30 Rogers S L , Doody R S , Mohs R C , Friedhoff L T . Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study . Archives of Internal Medicine , 1998 , 158 ( 9 ): 1021 – 1031 . 9588436 

31. 31 Rogers S L , Friedhoff L T . Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study . European Neuropsychopharmacology , 1998 , 8 ( 1 ): 67 – 75 . 9452942 

    상세보기

32. 32 Song Y H , Cai H , Gu N , Qian C F , Cao S P , Zhao Z M . Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure . J Pharm Pharmacol , 2011 ; 63 ( 4 ): 541 – 549 . 10.1111/j.2042-7158.2010.01241.x 21401606 

    상세보기

33. 33 Xu CQ , Liu BJ , Wu JF , Xu Y C , Duan X H , Cao Y X , et al Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-κB signaling pathway . Eur J Pharmacol , 2010 ; 642 ( 1–3 ): 146 – 153 . 10.1016/j.ejphar.2010.05.023 20519138 

    상세보기

34. 34 Zhou J , Wu J , Chen X , Fortenbery N , Eksioglu E , Kodumudi K N , et al Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions . Int Immunopharmacol , 2011 , 11 ( 7 ): 887 – 895 . 

35. 35 Zeng K W , Ko H , Yang H O , Wang X M . Icariin attenuates-amyloid-induced neurotoxicity by inhibition of tauprotein hyperphosphorylation in PC12 cells . Neuropharmacology , 2010 , 59 : 542 – 550 . 10.1016/j.neuropharm.2010.07.020 20708632 

    상세보기

36. 36 Zhang L , Shen C , Chu J , Zhang R , Li Y , Li L . Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease . International journal of biological sciences , 2014 , 10 ( 2 ): 181 – 191 . 10.7150/ijbs.6232 24550686 

    상세보기

37. 37 Wu B , Chen Y , Huang J , Ning Y , Bian Q , Shan Y , et al Icariin improves cognitive deficits and activates quiescent neural stem cells in aging rats . J. Ethnopharmacol . 2012 , 142 ( 3 ), 746 – 753 . 10.1016/j.jep.2012.05.056 22687254 

    상세보기

38. 38 Li F , Gong Q H , Wu Q , Lu Y F , Shi J S . Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats . Pharmacol Biochem Behav . 2010 , 96 ( 3 ), 301 – 305 . 10.1016/j.pbb.2010.05.021 20566405 

    상세보기

39. 39 Luo Y , Nie J , Gong Q H , Lu Y F , Wu Q , Shi J S . Protective effects of icariin against learning and memory deficits induced by aluminium in rats . Clin. Exp. Pharmacol. Physiol . 2007 , 34 ( 8 ), 792 – 795 . 17600559 

    상세보기

40. 40 Yu T G , Cheng C L , Ji C L , Xing G , Zhou L , Dong M , et al Beta-Asarone Improves Cognitive Function by Suppressing Neuronal Apoptosis in the Beta-Amyloid Hippocampus Injection Rats . Biol. Pharm. Bull . 2010 , 33 ( 5 ): 836 – 843 . 20460763 

    상세보기

41. 41 Ji C L , Cheng C , Gui H X , Zhou L , Dong M , Geng Y , et al Beta-Asarone Attenuates Neuronal Apoptosis Induced by Beta Amyloid in Rat Hippocampus . Yakugaku Zasshi , 2010 , 130 ( 5 ): 737 – 746 . 20460873 

    상세보기

42. 42 Kim M , Kim S , Lee M , Lee J H , Jung W S , Moon S K , et al Tetramethylpyrazine, a natural alkaloid, attenuates pro-inflammatory mediators induced by amyloid β and interferon-γ in rat brain microglia . European Journal of Pharmacology , 2014 , 740 : 504 – 511 . 10.1016/j.ejphar.2014.06.037 24975095 

    상세보기

43. 43 Zhao L , Wei MJ , He M , Jin W B , Zhao H S , Yao W F . The effects of tetramethylpyrazine on learning and memory abilities of mice with Alzheimer disease and its possible mechanism . Chin Pharmacol Bull , 2008 , 24 ( 8 ): 1088 – 92 . 

44. 44 Wang T , Gu J , Wu PF , Wang F , Xiong Z , Yang Y J , et al Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation . Free Radic. Biol. Med , 2009 , 47 ( 3 ): 229 – 240 . 10.1016/j.freeradbiomed.2009.02.027 19272442 

    상세보기

45. 45 Wang R , Tang Y , Feng B , Ye C , Fang L , Zhang L , et al Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats . Neuroscience , 2007 , 149 ( 4 ): 739 – 746 . 17935895 

    상세보기

46. 46 Zhang L , Xing Y , Ye CF , Ai H X , Wei H F , Li L . Learning-memory deficit with aging in APP transgenic mice of Alzheimer’s disease and intervention by using tetrahydroxystilbene glucoside . Behav. Brain Res , 2006 , 173 ( 2 ): 246 – 254 . 16901557 

    상세보기

47. 47 Zhou L , Hou Y , Yang Q , Du X , Li M , Yuan M , et al Tetrahydroxystilbene glucoside improves the learning and memory of amyloid-β(1–42)-injected rats and may be connected to synaptic changes in the hippocampus . Can. J. Physiol. Pharmacol , 2012 , 90 : 1446 – 1455 . 10.1139/y2012-121 23181273 

    상세보기

48. 48 Nadkarni NK , Black SE . Cognitive outcomes; in Rockwood K, Gauthier S (eds): Trial Designs and Outcomes in Dementia Therapeutic Research . Abingdon, Taylor & Francis , 2006 : 85 – 112 . 10.1080/19552068.2010.9635845 22081655 

    

49. 49 Mohs R C , Marin D , Green C R , Davis KL . The Alzheimer’s disease assessment scale: modifications that can enhance its use in future clinical trials. Alzheimer Disease . Birkhäuser Boston , 1997 : 407 – 411 . 

50. 50 Whitehead A , Perdomo C , Pratt R D , Birks J , Wilcock G K , Evans J G . Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer’s disease: a meta-analysis of individual patient data from randomised controlled trials . Int J Geriatr Psychiatry , 2004 , 19 ( 7 ): 624 – 633 . 15254918 

    상세보기

51. 51 Homma A , Imai Y , Tago H , Asada T , Shigeta M , Iwamoto T , et al Donepezil treatment of patients with severe Alzheimer’s disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial . Dement Geriatr Cogn Disord , 2008 , 25 ( 5 ): 399 – 407 . 10.1159/000122961 18391486 

    상세보기

52. 52 Nozawa M , Ichimiya Y , Nozawa E , Utumi Y , Sugiyama H , Murayama N , et al Clinical effects of high oral dose of donepezil for patients with Alzheimer’s disease in Japan . Psychogeriatrics , 2009 , 9 ( 2 ): 50 – 55 . 10.1111/j.1479-8301.2009.00291.x 19604325 

    상세보기

53. 53 Sasaki S , Horie Y . The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease . Dementia and Geriatric Cognitive Disorders Extra , 2014 , 4 ( 2 ): 131 – 139 . 10.1159/000362871 24987402 

    상세보기

54. 54 Sabbagh M , Cummings J , Christensen D , Doody R , Farlow M , Liu L , et al Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response . BMC geriatrics , 2013 , 13 ( 1 ): 56 . 23742728 

55. 55 Yatabe Y , Hashimoto M , Kaneda K , Honda K , Ogawa Y , Yuuki S , et al Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study . Psychogeriatrics , 2013 , 13 ( 2 ): 88 – 93 . 10.1111/psyg.12004 23909965 

    상세보기

56. 56 Farlow M R , Salloway S , Tariot P N , Yardley J , Moline M L , Wang Q , et al Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer’s disease: a 24-week, randomized, double-blind study . Clin Ther , 2010 , 32 ( 7 ): 1234 – 1251 . 10.1016/j.clinthera.2010.06.019 20678673 

    상세보기